Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biochemical Pharmacology|November 23, 2006
Irofulven induces replication-dependent CHK2 activation related to p53 statusYutian Wang, Timothy Wiltshire, Jamie Senft, et al.
Molecular Cancer Therapeutics|December 19, 2006
Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulvenYutian Wang, Timothy Wiltshire, Jamie Senft, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|July 14, 2022
The Pharmacogenetics of Opiates and Its Impact on Delirium in Mechanically Ventilated Adults: A Pilot StudyC Adrian Austin, Andy Szeto, Apoorva Gupta, et al.
Pharmacogenomics|August 14, 2010
Toxicogenetics: population-based testing of drug and chemical safety in mouse modelsIvan Rusyn, Daniel M Gatti, Timothy Wiltshire, et al.
Molecular Pharmacology|January 19, 2007
BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulvenTimothy Wiltshire, Jamie Senft, Yutian Wang, et al.
American Journal of Physical Medicine & Rehabilitation|May 20, 2026
Leading the Way: Cellular and Gene Therapies in Physical Medicine and Rehabilitation Transforming Functional Outcomes Through Regenerative InnovationShannon Strader, F Clay Smither, Monica Klein, et al.
The Journal of Biological Chemistry|July 23, 2004
ATM-dependent CHK2 activation induced by anticancer agent, irofulvenJian Wang, Timothy Wiltshire, Yutian Wang, et al.
Neuroreport|September 14, 2017
Impact of human CA8 on thermal antinociception in relation to morphine equivalence in miceEugene S Fu, Diana M Erasso, Gerald Z Zhuang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 23, 2019
Functional characterization of 84 PALB2 variants of uncertain significanceTimothy Wiltshire, Mandy Ducy, Tzeh Keong Foo, et al.
Pageof 2